NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
12/17/2024
Back to search
Official data from USPTO
ENTENDAMOS EL CANCER JUNTOS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
25
Latest update
12/17/2024
Trademark type
Combined
Nice classes
44, 45
Filing date
10/13/2022
Registration date
12/17/2024
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
12/17/2024
Last transaction
12/17/2024
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
12/31/2022
First use in commerce
12/31/2022
Drawing code
3
Owner type
16
Owner location
Rahway, NJ, US
Examiner
HOWELL,MATTHEW PATTERSON
Law office
L80
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of two peg figures next to each other alongside the words "ENTENDAMOS" above "EL CÁNCER JUNTOS".
Holders and representatives
Holders
Merck Sharp & Dohme LLC
Representatives
Lisa Dellamura MERCK & CO., INC.
Technical classification
Nice Classes
Class 44Class 45
Vienna Codes
No Vienna codes available.
Goods and services
Class 44
Patient support servicesproviding health and medical information; providing patient support services in the nature of providing information about cancer treatments; providing patient support services in the nature of providing information about cancer recovery and survival to help cancer patients and their families and friends cope with cancer
Class 45
Patient support services in the nature of providing information about emotional counseling and emotional support to help cancer patients and their families and friends cope with cancer
Publications
History of USPTO decisions and trademark events.
25 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
12/17/2024
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
11/25/2024
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
11/25/2024
SUPC
STATEMENT OF USE PROCESSING COMPLETE
11/22/2024
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
11/22/2024
IUAF
USE AMENDMENT FILED
09/18/2024
EISU
TEAS STATEMENT OF USE RECEIVED
09/18/2024
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
03/13/2024
EX1G
SOU EXTENSION 1 GRANTED
03/12/2024
EXT1
SOU EXTENSION 1 FILED
03/12/2024
EEXT
SOU TEAS EXTENSION RECEIVED
03/12/2024
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
09/19/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
07/25/2023
PUBO
PUBLISHED FOR OPPOSITION
07/25/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
07/05/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
06/21/2023
XAEC
EXAMINER'S AMENDMENT ENTERED
06/21/2023
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
06/21/2023
GNEA
EXAMINERS AMENDMENT E-MAILED
06/21/2023
CNEA
EXAMINERS AMENDMENT -WRITTEN
06/21/2023
DOCK
ASSIGNED TO EXAMINER
06/16/2023
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
10/28/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
10/27/2022
NWAP
NEW APPLICATION ENTERED
10/17/2022
Continuous trademark protection
Get notified about every new filing that threatens ENTENDAMOS EL CANCER JUNTOS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.